Do not apply the SRU algorithm directly if: the study is technically inadequate (short-interval follow-up US in 1–2 months); a >10 mm lesion cannot be distinguished from tumefactive sludge or adenomyomatosis (CEUS or MRI); there is high suspicion for an invasive/malignant tumor — wall invasion, concurrent liver masses, malignant biliary obstruction, or nodal enlargement (refer to oncologic specialist); or the patient has primary sclerosing cholangitis (use AGA/ACG specialty guidelines).
Extremely low risk: pedunculated "ball-on-the-wall" or pedunculated with a thin stalk. Low risk: pedunculated with a thick/wide stalk, or sessile (and when shape is uncertain). Indeterminate risk: focal wall thickening ≥4 mm adjacent to the polyp.
Extremely low: ≤9 mm no follow-up; 10–14 mm US at 6, 12, 24 months (surgical consult is an acceptable alternative); ≥15 mm surgical consult.
Low: ≤6 mm no follow-up; 7–9 mm US at 12 months; 10–14 mm US at 6, 12, 24, 36 months; ≥15 mm surgical consult.
Indeterminate: ≤6 mm US at 6, 12, 24, 36 months; ≥7 mm surgical consult.
At follow-up, an increase of ≥4 mm within a 12-month period, or reaching the category's surgical threshold (15 mm; 7 mm for indeterminate), warrants surgical consultation. A decrease of ≥4 mm → stop following. Maximum surveillance is 3 years.
Kamaya A, Fung C, Szpakowski JL, et al. Management of Incidentally Detected Gallbladder Polyps: Society of Radiologists in Ultrasound Consensus Conference Recommendations. Radiology 2022;305:277–289. Figures 1 and 2.